Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumours (CNS GCT)
Drugs used as chemotherapy, such as carboplatin, etoposide, and ifosfamide work in different
ways to stop the growth of tumour cells, either by killing the cells or by stopping them from
dividing. Radiation therapy uses high-energy x rays to kill tumour cells. Giving chemotherapy
with radiation therapy may kill more tumour cells. This phase II trial studies how well
chemotherapy and radiation therapy work in treating younger patients with newly diagnosed
central nervous system germ cell tumours.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society